Cyclica has been acquired by Recursion Pharma, please see the initial announcement here.
Recursion Canada Inc., a wholly-owned subsidiary of Recursion Pharmaceuticals, Inc. (“Recursion”), acquired all of the outstanding securities of Cyclica Therapeutics Inc. (the successor of Cyclica Inc. following a pre-closing reorganization) (“Cyclica”) near the end of May 2023. The result is that Cyclica has undergone a change of control and is now a wholly-owned, indirect subsidiary of Recursion.
Following the acquisition of Cyclica, we are no longer accepting any inquiries.
